Acesso livre
Acesso livre

Medicina de Emergências

As diretrizes WSES/SICG/ACOI/SICUT/AcEMC/SIFIPAC para diagnóstico e tratamento da diverticulite colônica esquerda aguda em idosos.

25 Jan, 2022 | 11:53h

The WSES/SICG/ACOI/SICUT/AcEMC/SIFIPAC guidelines for diagnosis and treatment of acute left colonic diverticulitis in the elderly – World Journal of Emergency Surgery

Conteúdos relacionados:

ACP Guideline: Diagnosis and management of acute left-sided colonic diverticulitis.

Review: Changing paradigms in the management of acute uncomplicated diverticulitis.

RCT: Another study shows that non-antibiotic outpatient treatment in mild acute diverticulitis is safe.

Review: Elective surgical management of diverticulitis

State of the Art Review | Management of colonic diverticulitis

Drains, germs, or steel: Multidisciplinary management of acute colonic diverticulitis

Randomized trial: Laparoscopic lavage vs. primary resection for perforated purulent diverticulitis; similar long-term results, but recurrence was more common after laparoscopic lavage

Randomized trial: In patients with recurrent, complicated, or persistent painful diverticulitis, sigmoid resection improved quality of life but was associated with a small but significant risk of major complications

Systematic review: Management of colonic diverticulitis

WSES Guidelines for the Management of Acute Colonic Diverticulitis

ASCRS Guidelines for the Treatment of Left-Sided Colonic Diverticulitis


Diretrizes perioperatórias sobre agentes antiplaquetários e anticoagulantes: atualização 2022.

21 Jan, 2022 | 15:48h

Perioperative Guidelines on Antiplatelet and Anticoagulant Agents: 2022 Update – Current Anesthesiology Reports


M-A | Em sobreviventes de parada cardíaca em coma, a hipotermia não está associada com melhora na sobrevida ou com melhores desfechos neurológicos vs. normotermia.

21 Jan, 2022 | 15:30h

Targeted Hypothermia Versus Targeted Normothermia In Survivors of Cardiac Arrest: A Systematic Review and Meta-Analysis of Randomized Trials – American Journal of Medicine

Conteúdos relacionados:

RCT: In comatose survivors of out-of-hospital cardiac arrest, there was no difference in mortality and neurologic outcomes with mild (target temperature of 34 °C) vs. moderate therapeutic hypothermia (target temperature of 31 °C).

M-A: Targeted temperature management following out-of-hospital cardiac arrest – “Routine use of moderate or deep hypothermia in comatose survivors of OHCA may potentially be associated with more harm than benefit”.

RCT: In patients with coma after out-of-hospital cardiac arrest, targeted hypothermia did not improve outcomes.


Estudo randomizado | Em pacientes não críticos internados com COVID-19, o uso de inibidor de P2Y12 (ticagrelor em 63% dos pacientes e clopidogrel em 37%) adicionado à dose terapêutica de heparina não melhorou a sobrevida livre de suporte de órgãos em comparação à heparina terapêutica isolada.

20 Jan, 2022 | 22:21h

Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non–Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical Trial – JAMA

Editorial: Antiplatelet Therapy in Patients With COVID-19—More Is Less? – JAMA

Comentário: Adding a P2Y12 Inhibitor Does Not Improve Outcomes in COVID-19 – HealthDay


Estudo randomizado | Em adultos com doença crítica, o uso de solução balanceada de multieletrólitos não reduziu o risco de morte ou lesão renal aguda em comparação à solução salina padrão.

20 Jan, 2022 | 22:05h

Balanced Multielectrolyte Solution versus Saline in Critically Ill Adults – New England Journal of Medicine (link para o resumo – $ para o texto completo)

Comentário: Australian study set to guide the treatment of critically ill patients worldwide – George Institute for Global Health

Conteúdos relacionados:

BaSICS RCT: Among critically ill patients requiring fluid therapy, treatment with a balanced solution did not lead to reduced mortality compared to a 0.9% saline solution.

BaSICS RCT: Among critically ill patients requiring fluid therapy, there was no difference in mortality with slower (333 mL/h) vs. faster (999 mL/h) intravenous fluid bolus rates.

Cochrane Review: Buffered Solutions Do Not Improve Mortality in Critically Ill Adults and Children Compared to 0,9% Saline

 

Comentário no Twitter

 


M-A | Avaliação de intervenções para reduzir a prescrição de opioides para pacientes após alta do departamento de emergência.

20 Jan, 2022 | 21:40h

Evaluation of Interventions to Reduce Opioid Prescribing for Patients Discharged From the Emergency Department: A Systematic Review and Meta-analysis – JAMA Network Open

Comentário convidado: Optimizing Opioid Prescriptions for Patients in the Emergency Department—How Much Is Almost Never? – JAMA Network Open

 

Comentário no Twitter

 


Evidências atualizadas da Cochrane sobre COVID-19.

20 Jan, 2022 | 21:33h

COVID-19 evidence: a Cochrane round-up – Cochrane Library


Diretriz ACP | Diagnóstico e tratamento da diverticulite colônica aguda de lado esquerdo.

20 Jan, 2022 | 21:09h

Diagnosis and Management of Acute Left-Sided Colonic Diverticulitis: A Clinical Guideline From the American College of Physicians – Annals of Internal Medicine

Diretriz relacionada: Colonoscopy for Diagnostic Evaluation and Interventions to Prevent Recurrence After Acute Left-Sided Colonic Diverticulitis: A Clinical Guideline From the American College of Physicians – Annals of Internal Medicine

Revisões sistemáticas relacionadas:

Diagnostic Imaging and Medical Management of Acute Left-Sided Colonic Diverticulitis: A Systematic Review – Annals of Internal Medicine

Evaluation and Management After Acute Left-Sided Colonic Diverticulitis: A Systematic Review – Annals of Internal Medicine

Resumo em vídeo: Diagnostic Imaging and Medical Management of Acute Left-Sided Colonic Diverticulitis: A Systematic Review – Annals of Internal Medicine

Comunicado de imprensa: ACP releases two new clinical guidelines on the diagnosis and management of diverticulitis – American College of Physicians


OMS recomenda dois novos medicamentos (baricitinibe e sotrovimabe) para tratar COVID-19.

20 Jan, 2022 | 20:20h

Comunicado de imprensa: WHO recommends two new drugs to treat COVID-19 – World Health Organization

Infográfico com recomendações atualizadas: A living WHO guideline on drugs for covid-19 – The BMJ

Comentários:

WHO Recommends Two New COVID-19 Treatments – Cost and Availability Likely Barriers – Health Policy Watch

Expert reaction to WHO recommending two drugs, sotrovimab and baricitinib, to treat patients with COVID-19 – Science Media Centre

 

Comentário no Twitter (fio – clique para saber mais)

 


Ponto de vista | Tratamentos para COVID-19 para pacientes não internados.

20 Jan, 2022 | 20:11h

COVID-19 Therapeutics for Nonhospitalized Patients – JAMA

Editorial: Realizing the Potential of Anti–SARS-CoV-2 Monoclonal Antibodies for COVID-19 Management – JAMA


Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.